There is no way of knowing but NXEN has a ton of potential and though we are not getting updates from management every week I do feel they have been consistent about updating us as progress is made.
On another note I was watching Fox Business at market open and they were discussing pot stocks and both analyst said they were buyers. The host asked about the moral side of things and one of the analysts rebutted beautifully essentially saying that with the opioid and other health issues MMJ is able to treat that it would be immoral not to support investment into the field.
In short I think the tides will quickly turn for MMJ in the US now that Sessions is out and with NXEN joining the CSX we will catch a bump from that and I could see another bump this summer if the US review legalization which I believe is likely to happen. With this leadership team and patent pending research NXEN should stand out above most to funds.
News 
Market Data 
Discover 
